Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
Diseases of the Cardiovascular System
What is the purpose of this trial?
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
- Ages18 years and older
- Trial withBoston Scientific Corporation
- Start Date01/27/2022
- End Date01/01/2028
- Last Updated02/15/2022
- Study HIC#2000031921REG